Canadian Glycomics Network

Tag: Avivo

GlycoNet startup Avivo awarded $10.9 M to advance technology for universal blood and organs

GlycoNet startup Avivo awarded $10.9 M to advance technology for universal blood and organs

Avivo was one of five companies selected for funding under the Government of Canada’s Life Sciences Fund to advance dual-use innovations and strengthen Canada’s industrial capacity.

GlycoNet startup Avivo achieves world’s first blood type A-to-O kidney transplant, a breakthrough for universal donor organs

GlycoNet startup Avivo achieves world’s first blood type A-to-O kidney transplant, a breakthrough for universal donor organs

The successful transplant marks major progress towards more compatible, accessible organs for patients.

Scroll to Top